Kenya Airways through its cargo arm KQ Cargo, has unveiled an ultra-modern pharma facility at the Jomo Kenyatta International Airport (JKIA), to help meet the demand for medical shipments around the world.
According to Dick Murianki, KQ Cargo Director, the facility’s immediate focus will be improving logistics in distributing a potential COVID-19 vaccine in Africa.
“KQ Cargo has been laying the groundwork and working closely with pharmaceutical and medical customers to be ready to safely and effectively support their vaccines transportation needs to move efficiently once the vaccine is approved by the regulators,” says Mr. Murianki. “The investment in the ultra-modern pharma facility, though coinciding with COVID-19 pandemic, is to further meet the demand of pharmaceutical products globally in preparation for the big task of transporting medicines, vaccines, blood samples and temperature-sensitive cargo by having an end-to-end cold chain logistics solutions,” he added.
Since March this year, the national carrier has transported vital goods and medical supplies, about 6,000 tonnes of much-needed medical equipment to help fight the COVID-19 pandemic.
The Jomo Kenyatta International Airport (JKIA) in Nairobi, has been a distribution and logistics hub in Africa and has been rated as the second fastest-growing airport in the world for cargo by ACI in 2019.
KQ has also linked up with global leaders in cold chain solutions to offer active and passive packaging with dedicated equipment to perform seamless cold chain operations.
Source: CGTN Africa